This company is no longer active
Ceapro Balance Sheet Health
Financial Health criteria checks 6/6
Ceapro has a total shareholder equity of CA$27.9M and total debt of CA$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CA$31.4M and CA$3.6M respectively.
Key information
0%
Debt to equity ratio
CA$0
Debt
| Interest coverage ratio | n/a |
| Cash | CA$8.84m |
| Equity | CA$27.86m |
| Total liabilities | CA$3.59m |
| Total assets | CA$31.45m |
Recent financial health updates
Recent updates
The Returns At Ceapro (CVE:CZO) Aren't Growing
Aug 09
Returns At Ceapro (CVE:CZO) Are On The Way Up
Oct 15Ceapro's (CVE:CZO) Returns Have Hit A Wall
Jun 17Ceapro (CVE:CZO) Will Want To Turn Around Its Return Trends
Nov 19Be Wary Of Ceapro (CVE:CZO) And Its Returns On Capital
Jul 20Ceapro's (CVE:CZO) Robust Earnings Are Supported By Other Strong Factors
May 27Estimating The Fair Value Of Ceapro Inc. (CVE:CZO)
Apr 29Will Ceapro (CVE:CZO) Multiply In Value Going Forward?
Mar 01Is It Too Late To Consider Buying Ceapro Inc. (CVE:CZO)?
Feb 01Estimating The Fair Value Of Ceapro Inc. (CVE:CZO)
Jan 06
Ceapro Inc. (CVE:CZO) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Nov 28Financial Position Analysis
Short Term Liabilities: CZO's short term assets (CA$14.8M) exceed its short term liabilities (CA$1.7M).
Long Term Liabilities: CZO's short term assets (CA$14.8M) exceed its long term liabilities (CA$1.9M).
Debt to Equity History and Analysis
Debt Level: CZO is debt free.
Reducing Debt: CZO has no debt compared to 5 years ago when its debt to equity ratio was 2.7%.
Debt Coverage: CZO has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: CZO has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/06/03 22:20 |
| End of Day Share Price | 2024/06/03 00:00 |
| Earnings | 2023/12/31 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ceapro Inc. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ahu Demir | NOBLE Capital Markets, Inc. |
| Cosme Ordoñez | NOBLE Capital Markets, Inc. |
| Nisha Hirani | Zacks Investment Research Inc. |